# Factors associated with stroke recurrence and mortality in ischemic and haemorrhagic stroke: Protocol for a systematic review and meta-analysis

**Authors:** Simone Ryan, Katie Robinson, Rose Galvin, Margaret O’Connor, John McCabe, Eleanor Fallon, Sara Hayes, Eyob Alemayehu Gebreyohannes, Eyob Alemayehu Gebreyohannes, Eyob Alemayehu Gebreyohannes

PMC · DOI: 10.1371/journal.pone.0329932 · PLOS One · 2025-08-14

## TL;DR

This study will review risk factors for stroke recurrence and death in ischemic and hemorrhagic stroke patients to improve prevention strategies.

## Contribution

The study addresses gaps in existing reviews by considering both clinical and lifestyle factors across all stroke subtypes and populations.

## Key findings

- Recurrent strokes lead to higher mortality and worse outcomes than first strokes.
- The review will identify risk factors to guide secondary stroke prevention.
- A systematic search and meta-analysis will assess the impact of various risk factors.

## Abstract

Stroke is one of the leading causes of death and disability worldwide. People with stroke face a significant risk of recurrence, however, there is a lack of consensus on the risk factors for stroke recurrence. Previous systematic reviews in this area are either outdated, focus exclusively on clinical risk factors, or are limited by geographical region, stroke subtype or age group. This review aims to systematically identify clinical and lifestyle risk factors associated with stroke recurrence and mortality in people with stroke.

A systematic search will be conducted in four electronic databases (PubMed, EMBASE, CINAHL and PsycINFO) and grey literature sources. Only prospective cohort studies that estimate the association between risk factors and stroke recurrence and/or mortality in adults with ischemic and haemorrhagic stroke will be included. The exposures of interest are clinical and lifestyle risk factors, including vascular and cardiac factors such as hypertension or atrial fibrillation, and behavioural factors such as physical activity, nutrition, or smoking. Two independent reviewers will conduct screening, data extraction, and risk of bias assessment using the ROBINS-E tool, while the GRADE approach will be used to evaluate the certainty of evidence. A meta-analysis using a random-effects model will be used to determine the overall effect for each exposure on stroke recurrence and/or mortality. However, if a meta-analysis is not justified, a narrative synthesis will instead be conducted.

Recurrent strokes are associated with greater mortality and poorer functional prognosis than first-time events, imposing greater economic burden on healthcare services. This review will identify factors that increase one’s risk for recurrence, thereby informing the development and refinement of clinical guidance for secondary stroke prevention; a key priority for both those living with stroke and the wider health service.

## Linked entities

- **Diseases:** stroke (MONDO:0005098), atrial fibrillation (MONDO:0004981)

## Full-text entities

- **Diseases:** Stroke (MESH:D020521), neurological deterioration (MESH:D009422), aneurysm rupture (MESH:D017542), patent foramen ovale (MESH:D054092), death (MESH:D003643), seizure (MESH:D012640), heart disease (MESH:D006331), sleep apnoea (MESH:D012891), coronary heart disease (MESH:D003327), cardiovascular disease (MESH:D002318), myocardial infarction (MESH:D009203), large artery thrombosis (MESH:D002341), cerebral amyloid angiopathy (MESH:D016657), heart or respiratory failure (MESH:D012131), pneumonia (MESH:D011014), cryptogenic stroke (MESH:D000083242), brain oedema (MESH:D001929), thrombotic stroke (MESH:D000083244), disturbance of cerebral function (MESH:D003291), migraine (MESH:D008881), cardiogenic embolism (MESH:D013575), hypertension (MESH:D006973), diabetes mellitus (MESH:D003920), obstructive sleep apnoea (MESH:D020181), SAH (MESH:D013345), atrial fibrillation (MESH:D001281), haemorrhagic (MESH:D006470), sepsis (MESH:D018805), ICH (MESH:D002543), TIA (MESH:D002546), ischemic stroke (MESH:D002544), neurological deficits (MESH:D009461), embolic stroke (MESH:D000083262), chronic kidney disease (MESH:D051436), obesity (MESH:D009765), ischemic (MESH:D002545)
- **Chemicals:** alcohol (MESH:D000438), glucose (MESH:D005947), PONE-D-25-10654R1 (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12352634/full.md

## References

41 references — full list in the complete paper: https://tomesphere.com/paper/PMC12352634/full.md

---
Source: https://tomesphere.com/paper/PMC12352634